Gtlf3a Inhibitors
Chemical inhibitors of Gtlf3a operate through diverse mechanisms, each targeting different aspects of the protein's activation and function by affecting phosphorylation states, which are critical for Gtlf3a's regulation. For instance, phenylarsine oxide disrupts tyrosine phosphatase activity, leading to a sustained phosphorylation state of proteins that are upstream of Gtlf3a. This action culminates in the functional inhibition of Gtlf3a, as it hampers the protein's ability to undergo activation through dephosphorylation processes. Similarly, genistein targets tyrosine kinases, enzymes responsible for the addition of phosphate groups to proteins. By inhibiting these kinases, genistein reduces the phosphorylation levels of essential proteins for Gtlf3a activation, therefore functionally inhibiting Gtlf3a. Staurosporine contributes to the inhibition spectrum by broadly targeting protein kinases, which would typically phosphorylate Gtlf3a or its associated proteins, thus preventing its functional activation.
Additionally, the chemical inhibitors wortmannin and LY294002 share a common target in phosphoinositide 3-kinases (PI3K), leading to a decrease in PI3K-mediated signaling pathways essential for Gtlf3a activity. By inhibiting this pathway, both chemicals ensure a reduction in the activation of downstream proteins that are necessary for Gtlf3a function. MEK inhibitors PD98059 and U0126, by selectively inhibiting MEK1/2, culminate in downregulation of the ERK pathway, which is often implicated in the activation of various proteins, including Gtlf3a, thus functionally inhibiting it. The p38 MAP kinase pathway, another signaling route, can be interrupted by SB203580, which in turn inhibits the activation of proteins under this pathway's influence, possibly including Gtlf3a. SP600125's inhibition of c-Jun N-terminal kinase (JNK) decreases signaling required for Gtlf3a's activity. Gö6976 specifically inhibits protein kinase C (PKC), which is involved in signaling pathways that may activate Gtlf3a, leading to a decrease in Gtlf3a activation. Collectively, these inhibitors modulate the phosphorylation landscape that Gtlf3a relies upon for its functional state, thereby controlling its activity through various signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
Phenylarsine oxide is known to inhibit the function of tyrosine phosphatases. Since Gtlf3a is involved in a phosphorylation-dependent signaling pathway, the inhibition of phosphatases by phenylarsine oxide can result in the sustained phosphorylation of proteins upstream of Gtlf3a, which can lead to the functional inhibition of Gtlf3a by preventing it from being activated through dephosphorylation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By inhibiting tyrosine kinases, genistein can reduce the phosphorylation of proteins that are necessary for the activation of Gtlf3a. As Gtlf3a activity is dependent on the phosphorylation state of these proteins, genistein thereby functionally inhibits Gtlf3a by reducing the requisite phosphorylation signals. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Gtlf3a, being regulated by phosphorylation events, can be functionally inhibited by staurosporine because it prevents the activation of kinases that would normally phosphorylate and activate Gtlf3a. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin acts as an inhibitor of phosphoinositide 3-kinases (PI3K). PI3K pathways are often involved in the activation of downstream proteins, which could include Gtlf3a. Inhibition of PI3K leads to a decrease in the activation of these pathways, thereby functionally inhibiting Gtlf3a activity through the reduction of downstream signaling required for its activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Similar to wortmannin, LY294002 is another inhibitor of PI3K, and it functions to decrease PI3K pathway signaling. Reduced PI3K signaling can result in the decreased activity of downstream proteins and pathways that are necessary for the proper function of Gtlf3a, hence functionally inhibiting Gtlf3a. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which is upstream of the ERK pathway. The ERK pathway is a common signaling mechanism that can lead to the activation of a variety of proteins, potentially including Gtlf3a. By inhibiting MEK, PD98059 can suppress ERK pathway signaling, which can lead to the functional inhibition of Gtlf3a if Gtlf3a is dependent on this pathway for its activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a non-competitive inhibitor of MEK1/2 which leads to the inhibition of the ERK pathway. Inhibition of the ERK pathway can functionally inhibit Gtlf3a by preventing the necessary phosphorylation and activation of proteins within this pathway that would contribute to the functional activity of Gtlf3a. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. The p38 MAP kinase pathway is involved in cellular responses to stress and inflammation, and can contribute to the activation of various proteins, potentially including Gtlf3a. Inhibition of p38 MAP kinase by SB203580 can lead to the functional inhibition of Gtlf3a by reducing the activity of this signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). JNK signaling affects a wide range of cellular processes and can be implicated in the activation of certain proteins. By inhibiting JNK, SP600125 can decrease the signaling that might be necessary for the functional activity of Gtlf3a, thereby inhibiting it. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is a selective inhibitor of protein kinase C (PKC). PKC is involved in a variety of cellular signaling pathways, including those that may activate Gtlf3a. Inhibition of PKC by Gö6976 can lead to a decrease in the signaling pathways that activate Gtlf3a, thus functionally inhibiting it. | ||||||